安徽医学
安徽醫學
안휘의학
ANHUI MEDICAL JOURNAL
2014年
5期
568-571
,共4页
吴凡%翟志敏%刘周%秦慧
吳凡%翟誌敏%劉週%秦慧
오범%적지민%류주%진혜
血液病患者%血流感染%致病菌%耐药性
血液病患者%血流感染%緻病菌%耐藥性
혈액병환자%혈류감염%치병균%내약성
Hematologic patients%Blood stream infection%Bacterium%Drug resistance
目的:分析血液病患者发生血流感染的病原菌分布情况及耐药性,为临床合理使用抗菌药物、有效控制感染提供可靠依据。方法回顾分析64例血流感染患者临床资料,了解其临床特点、血流感染病原菌种类及药敏情况。结果64例血流感染患者送检的272份血液标本中共培养出77株(28.30%)病原菌,其中G-菌60株(占77.92%)、G+菌14株(占18.18%)、真菌3株(3.90%),1例患者发生混合细菌感染。分离的病原菌中,主要为大肠埃希菌(41.55%)、肺炎克雷伯菌(12.99%)、凝固酶阴性葡萄球菌(11.69%)、金黄色葡萄球菌属(3.90%)。产超广谱β-内酰胺酶(ESBLs)的大肠埃希菌、肺炎克雷伯菌检出率分别为71.88%和50.00%;耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)的检出率分别为33.33%和88.88%。G-菌对美罗培南、哌拉西林-他唑巴坦、阿米卡星耐药率低,葡萄球菌对万古霉素、利奈唑胺、利福平耐药率低。结论引起血液病患者出现血流感染的主要致病菌为G-菌,对G-菌及G+菌最敏感的药物分别为美罗培南及万古霉素、利奈唑胺,建议选用抗G-菌为主、兼顾G+菌的抗菌药物进行经验性治疗,必要时加用抗真菌药物。
目的:分析血液病患者髮生血流感染的病原菌分佈情況及耐藥性,為臨床閤理使用抗菌藥物、有效控製感染提供可靠依據。方法迴顧分析64例血流感染患者臨床資料,瞭解其臨床特點、血流感染病原菌種類及藥敏情況。結果64例血流感染患者送檢的272份血液標本中共培養齣77株(28.30%)病原菌,其中G-菌60株(佔77.92%)、G+菌14株(佔18.18%)、真菌3株(3.90%),1例患者髮生混閤細菌感染。分離的病原菌中,主要為大腸埃希菌(41.55%)、肺炎剋雷伯菌(12.99%)、凝固酶陰性葡萄毬菌(11.69%)、金黃色葡萄毬菌屬(3.90%)。產超廣譜β-內酰胺酶(ESBLs)的大腸埃希菌、肺炎剋雷伯菌檢齣率分彆為71.88%和50.00%;耐甲氧西林金黃色葡萄毬菌(MRSA)和耐甲氧西林凝固酶陰性葡萄毬菌(MRCNS)的檢齣率分彆為33.33%和88.88%。G-菌對美囉培南、哌拉西林-他唑巴坦、阿米卡星耐藥率低,葡萄毬菌對萬古黴素、利奈唑胺、利福平耐藥率低。結論引起血液病患者齣現血流感染的主要緻病菌為G-菌,對G-菌及G+菌最敏感的藥物分彆為美囉培南及萬古黴素、利奈唑胺,建議選用抗G-菌為主、兼顧G+菌的抗菌藥物進行經驗性治療,必要時加用抗真菌藥物。
목적:분석혈액병환자발생혈류감염적병원균분포정황급내약성,위림상합리사용항균약물、유효공제감염제공가고의거。방법회고분석64례혈류감염환자림상자료,료해기림상특점、혈류감염병원균충류급약민정황。결과64례혈류감염환자송검적272빈혈액표본중공배양출77주(28.30%)병원균,기중G-균60주(점77.92%)、G+균14주(점18.18%)、진균3주(3.90%),1례환자발생혼합세균감염。분리적병원균중,주요위대장애희균(41.55%)、폐염극뢰백균(12.99%)、응고매음성포도구균(11.69%)、금황색포도구균속(3.90%)。산초엄보β-내선알매(ESBLs)적대장애희균、폐염극뢰백균검출솔분별위71.88%화50.00%;내갑양서림금황색포도구균(MRSA)화내갑양서림응고매음성포도구균(MRCNS)적검출솔분별위33.33%화88.88%。G-균대미라배남、고랍서림-타서파탄、아미잡성내약솔저,포도구균대만고매소、리내서알、리복평내약솔저。결론인기혈액병환자출현혈류감염적주요치병균위G-균,대G-균급G+균최민감적약물분별위미라배남급만고매소、리내서알,건의선용항G-균위주、겸고G+균적항균약물진행경험성치료,필요시가용항진균약물。
Objective To study the distribution and drug resistance of blood stream infection(BSI)in hematologic patients,so as to guide the clinical use of antibiotics.Methods Sixty-four BSI patients hospitalized from Jan 2010 to Oct 2013 were enrolled to perform retro-spective analysis on clinic data in order to understand the clinical features,the bacterial identification and drug sensitivity.Results All pa-tients had fever,and 74.03%had infection lesions,mostly in lungs.A total of 77 strains(28.30%)of pathogenic bacteria were isolated,inclu-ding 60 gram-negative (77.92%),14 gram-positive (18.18%)and 3 fungi(3.90%).Mixed infection was found in 1 patient.The isolated pathogenic bacteria were mainly Escherichia coli (41.55%),klebsiella pneumonia (12.99%),coagulase-negative staphylococci (11.69%) and staphylococci aureus(3.90%).The detection rates of Escherichia coli and klebsiella pneumonia producing super spectrum βlactamases (ESBLs)were 71.88% and 50.00%,respectively;those of methicillin resistant S aureus (MRSA)and meticillin resistant coagulase-nega-tive staphylococcus(MRCNS)were 33.33% and 88.88%,respectively.Gram-negative bacilli were relatively susceptible to meropenem,pip-eracillin-tazobactam and amikacin.Staphylococcus isolates were susceptible to vancomycin,linezolid and rifampicin.Conclusion The patho-genic bacteria inducing BSI are mainly gram negative,especially the Escherichia coli,bacteria.For G+and G-bacteria,meropenem and van-comycin linezolid are the most sensitive drugs respectively.It is suggested that empirical treatment of antimicrobial agents like anti G-bacteria and G+bacteria should be used,and antifungal drugs should be added when necessary.